---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-23-010412"
form_type: "8-K/A"
ticker: "OCEA"
cik: "0001869974"
company_name: "Ocean Biomedical, Inc."
filed_at: "2023-03-31T23:59:59+00:00"
generated_at: "2026-06-17T08:28:45.627284+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# Ocean Biomedical files audited FY2022 financials; auditor flags going concern with $34K cash vs $12.7M liabilities

## Summary
- Cash at Dec 31, 2022: $34K; total current liabilities $12.7M; working capital deficit of $10.8M.
- Auditor's report includes going-concern emphasis: substantial doubt about ability to continue.
- Net loss for FY2022 not disclosed in this excerpt, but accumulated deficit and negative equity implied.
- Deferred offering costs of $1.8M suggest ongoing capital-raising efforts.
- Short-term loans of $776K outstanding; accounts payable and accrued expenses $11.4M.

## SEC filing metadata
- accession: 0001493152-23-010412
- form_type: 8-K/A
- ticker: OCEA
- cik: 0001869974
- company_name: Ocean Biomedical, Inc.
- filed_at: 2023-03-31T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1869974/000149315223010412/0001493152-23-010412-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1869974/000149315223010412/form8-ka.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-23-010412
- JSON: https://secwatch.observer/filing/0001493152-23-010412.json
- Plain text: https://secwatch.observer/filing/0001493152-23-010412.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.